MENU
IONS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ionis Pharmaceuticals (IONS) Ownership - Who owns Ionis Pharmaceuticals?
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.98B
P/E Ratio
N/A
Total Cash
2.29B
Projected Growth
N/A
Total Debt
1.42B
Revenue
944.05M
Risk (Beta)
0.18
Dividend Yield
N/A
Total Cash/Share
14.37
Total Debt/Equity
N/A
Revenue/Share
6.05 USD as % of share price
Fundamentals
IONS
Capitalization
6.98B
P/E Ratio
N/A
Risk (Beta)
0.18
Dividend Yield
N/A
Total Cash
2.29B
Total Cash/Share
14.37
Total Debt
1.42B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.05%
Revenue
944M
ROE
N/A
Book Value
632M
P/B Ratio
11.05
Cash Flow
N/A
Earnings
-1.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
159K
Current Ratio
2.87
Current Revenue Per Employee
487647.25
Dividends Per Share - Security
N/A
EBITDA
-170.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.08
Revenue To Assets
-9.45
Shares Held By Institutions
14.3B
Shares Outstanding - Current
159M
Total Liabilities
2.35B
Total Volume MTD
N/A
Value
-1
Gain YTD
25.229
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IONS showed earnings on July 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of antisense drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com